Patents by Inventor Michael Verneris

Michael Verneris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230355675
    Abstract: Embodiments of the instant disclosure relate to novel compositions, methods and systems for generating ILC cells. In certain embodiments, the present disclosure provides for a composition including a hematopoietic progenitor cell expressing CD48 and at least one of a CD48 ligand, a CD48 agonist or a CD48 antagonist in order to induce production of ILC2 or ILC3 (for example, NCR+ ILC3 and LTi-ILC3) cell populations. In other certain embodiments, the present disclosure provides methods of treating one or more health condition or immune-mediated condition in a subject by administering an effective amount of a composition of ILC2 or ILC3 cells generated using methods disclosed herein.
    Type: Application
    Filed: March 28, 2023
    Publication date: November 9, 2023
    Inventors: Michael Verneris, Dejene Tufa
  • Patent number: 9862928
    Abstract: The present invention relates generally to methods to prepare NK and LTi-like, NK22 cells from HSCs and uses of those cells.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: January 9, 2018
    Assignee: Regents of the University of Minnesota
    Inventors: Michael Verneris, Jeff Miller, Bruce Blazar, Yong-Oon Ahn
  • Publication number: 20140072545
    Abstract: The present invention relates generally to methods to prepare NK and LTi-like, NK22 cells from HSCs and uses of those cells.
    Type: Application
    Filed: December 2, 2011
    Publication date: March 13, 2014
    Applicant: REGENTS OF THE UNIVERSITY OF MINNESOTA
    Inventors: Michael Verneris, Jeff Miller, Bruce Blazar, Yong-Oon Ahn